Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT01673178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Placebo-controlled, Randomized Trial To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Iv Doses Of Pf-05231023 In Obese Hyperlipidemic Adult Subjects With And Without Type 2 Diabetes Mellitus On A Background Of Atorvastatin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a trial in obese subjects who have poor lipid control with and without Type 2 diabetes mellitus to study the safety, tolerability and pharmacokinetics of multiple doses of PF-05231023
Study identification
- NCT ID
- NCT01673178
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- Placebo Other
- 25 mg PF-05231023 Drug
- 50 mg PF-05231023 Drug
- 100 mg PF-05231023 Drug
- 150 mg PF-05231023 Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 30 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2012 (Type not available)
- Primary completion
- Aug 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Feb 16, 2015
2012 – 2013
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| Profil Institute for Clinical Research, Inc. | Chula Vista | California | 91911 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| Avail Clinical Research, LLC | DeLand | Florida | 32720 | — |
| Elite Research Institute | Miami | Florida | 33169 | — |
| Miami Research Associates, Inc. | South Miami | Florida | 33143 | — |
| MRA Clinical Research, LLC | South Miami | Florida | 33143 | — |
| Central Kentucky Research Associates, Inc. | Lexington | Kentucky | 40509 | — |
| L-MARC Research Center | Louisville | Kentucky | 40213 | — |
| Prism Research | Saint Paul | Minnesota | 55114 | — |
| High Point Clinical Trials Center, LLC | High Point | North Carolina | 27265 | — |
| Carolina Phase 1 Research | Raleigh | North Carolina | 27612 | — |
| Wake Internal Medicine Consultants | Raleigh | North Carolina | 27612 | — |
| Medpace Clinical Pharmacology Unit | Cincinnati | Ohio | 45227 | — |
| Community Research | Cincinnati | Ohio | 45255 | — |
| Mercy Hospital Pharmacy | Cincinnati | Ohio | 45255 | — |
| Covance Clinical Research Unit | Dallas | Texas | 75247 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01673178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2015 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01673178 live on ClinicalTrials.gov.